NOVASOME: A PIONEERING ADVANCEMENTIN VESICULAR DRUG DELIVERY
Keywords:Drug delivery, Novasome, Application, Formulation, Characteristics
Pharmaceutical research has developed various new types of innovative forms of drug delivery. Advancement in current drug delivery methods has led to the development of numerous new revolutionary technologies that support safe and efficient formulations over existing ones. Novasome technology is one of the latest liposome developments that have overcome many of the liposomal drug delivery system-related problems. This provides a seven bilayer membrane which is capable of absorbing water-soluble as well as insoluble drugs. The improved efficiency of entrapping drugs with good encapsulation features enables better frequency of dosing, which can be accomplished through the high shear system. These find their applications in diverse fields such as cosmetics, chemicals, personal care, food, pharmacy, and agrochemicals. Several products have already been launched into the market using this technology with an additional launch plan. Due to its depth of penetration, novasomes have been one of the most popular derma cosmetics. It is being studied continuously to obtain improved release characteristics. The prospect of drug delivery and targeting using novasomes is an important area of research and development. This review pinpoints the various aspect of the novasome and will be a milestone for the researchers in the area of drug delivery.
Allen TM. Liposomal drug formulations: Rationale for development and what we can expect for the future. Drugs 1998;56:747–56.
Kalra N, Dhanya V, Saini V, Jeyabalan G. Virosomes: as a drug delivery carrier. Am J Adv Drug Delivery2013;1:29-35.
Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery-an overview. Acta Pharm Sin B 2011;1:208–19.
Aiswarya MU, Raju K, Menon RB, Lakshmi VS, Nair SC. Cryptosomes: a revolutionary breakthrough in novel drug delivery. Int J Appl Pharm 2019;11:7-13.
Lasic DD. Liposomes and niosomes. In: Rieger MM, Rhein LD. eds. Surfactants in Cosmetics. 2d ed. New York: Marcel Dekker; 1997. p. 263-83.
Kersten GF, Crommelin DJ. Liposomes and ISCOMs. Vaccine 2003;21:915-20.
Chambers MA, Wright DC, Brisker J. A single dose of killed mycobacterium bovis BCG in a novel class of adjuvant (Novasome) protects guinea pigs from lethal tuberculosis. Vaccine 2004;22:1063-71.
AbdElal RM, Shamma RN, Rashed HM, Bendas ER. Trans-nasal zolmitriptannovasomes: in vitro preparation, optimization and in vivo evaluation of brain targeting efficiency. Drug Delivery 2016;23:3374-86.
Daraee H, Etemadi A, Kouhi M, Alimirzalu S, Akbarzadeh A. Application of liposomes in medicine and drug delivery. Artif Cells NanomedBiotechnol 2016;44:381–91.
Sen R, Sahoo SK, Satpathy S. Liposomes as drug delivery system: a brief review. Int J Res Pharm Sci 2014:5:309-21.
Allen TM, Chonn A. Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett 1987;223:42–6.
Shinde GV. Supercritical fluids-a potential approach for novel drug formulation-a review. J Global PharmaTechnol 2010;2:1-6.
Rajera R, Nagpal K, Singh SK, Mishra DN. Niosomes: a controlled and novel drug delivery system. Biol Pharm Bull 2011;34:945-53.
Agarwal S, Kamala kumari PV. Advances in novasome technology-a review. Int J Appl Pharm 2013;5:1-4.
Kaur M.A review on novasome technology. IJPPR Human 2020;17:93-101.
Pinsky MA. Materials and methods for delivering antioxidants into the skin. U. S. patent application publication. [International Publication Number (WO 2008/089408 A1)]; 2008.
https://www.thefreelibrary.com/Terminalia+chebula-a0448031361. [Last accessed on 20 Jul 2020]
Kadian R. Nanoparticles: a promising drug delivery approach. Asian J Pharm Clin Res 2018;11:30-5.
Lipowsky R, Sackmann E. editors. The structure and dynamics of membranes. Amsterdam: Elsevier Science; 1995.
Sahin NO. Niosomes as nanocarrier systems. In: Mozafari MR.eds. Nanomaterialsand nanosystems for biomedical applications. Springer, Dordrecht; 2007. p. 67-81.
Nasir A, Harikumar SL, Amanpreet K. Niosomes: an excellent tool for drug delivery. Int J Pharm 2012;2:479-87.
Mills R, Mathur R, Lawrence N. Mahoniaaquifolim extract, extraction process and pharmaceutical composition containing the same. U. S. Patent Application Publication. [International Publication Number (WO 2005/027945 A1)]; 2005.
Singh A, M Rishabha, Sharma PK. Novasome-a breakthrough in pharmaceutical technology a review article. AdvBiol Res 2011;5:184-9.
Khan R, Irchhaiya R. In vitroin vivo evaluation of niosomal formulation of famotidine. Int J Pharm PharmSci 2020;12:15-22.
Wallach DFH, Mathur R, Redziniack GJM, Tranchant JF. Some properties of N-acyl sarcosinate lipid vesicles. J SocCosmetChem 1992;43:113-8.
Ghorab M, Gardouh A, Gad S. Effect of viscosity, surfactant type and concentration on physicochemical properties of solid lipid nanoparticles. Int J Pharm PharmSci2015;7:145-53.
Frezard F. Liposomes: from biophysics to the design of peptide vaccines. Braz J Med Biol Res 1999;32:181-9.
Mozafari MR. editor. Nanomaterials and nanosystems for biomedical applications. Springer Sci Rev 2007:67-81. DOI:10.1007/978-1-4020-6289-6
Raju K, PS G, Krishnakumar G, Nair SC. Vesosomes: new prospects in multi compartment vesicular drug delivery system. IJPR 2020;12:869-77.
Singh A, Malviya R, Sharma PK. Novasome-a breakthrough in pharmaceutical technology a review article. AdvBiol Res 2011;5:184-9.
https://www.cosmeticsdesign.com/Article/2004/10/22/Universe-Cosmetics-licenses-ingredient-release-tech. [Last accessed on 20 Jul 2020]
Niemiec SM, Ramachandran C, Weiner N. Influence of nonionic liposomal composition on topical delivery of peptide drugs into pilosebaceous units: an in vivo study using the hamster ear model. Pharm Res 1995;12:1184-8.
Toppo FA, Pawar RS. Novel drug delivery strategies and approaches for wound healing managements. J Crit Rev 2015;2:12-20.
http://www.catalog.md/drugs/nova-pearls.html [Last accessed on 20 Jul 2020]
Madni A, Sarfraz M, Rehman M, Ahmad M, Akhtar N, Ahmad S, et al. Liposomal drug delivery: a versatile platform for challenging clinical applications. J Pharm PharmSci 2014;17:401-26.
Revathy B Menon, Lakshmi VS, Aiswarya MU, KeerthanaRaju, Nair SC.Porphysomes-a paradigm shift in targeted drug delivery. Int J Appl Pharm 2018;10:1-6.
Waghmare S, Patil A, Patil P. Novasome: advance in liposome and niosome. J Pharm Innov 2016;5:34-8.
Abdelgawad R, Nasr M, Hamza MY. Topical and systemic dermal carriers for psoriasis. Int J Curr Pharm Res 2016;8:4-9.
https://www.drugs.com/vet/micro-pearls-advantage-dermal-soothe-anti-itch-spray.html. [Last accessed on 20 Jul 2020]
Williams AC. Transdermal and topical drug delivery from theory to clinical practice. Pharm Press 2003;4:49-50.
http://www.businesswire.com/news/home/20050127005465/en/Studies-Show-IGIs-Novasome-MicroencapsulationTechnology-Improves. [Last accessed on 20 Jul 2020]
Buena NJ. IGI Granted patent on novasome(R) encapsulated fuel additives. Free Library. Available from: http://www.thefreelibrary.com. [Last accessed on 20 Jul 2020]
Sharma S, Yadav G, GS. Accrediting gene therapies with non-viral lipid nanoparticles delivery system and its related pertinence. JCR 2020;7:11-15.
Hu C, Rhodes DG. Proniosomes: a novel drug carrier preparation. Int J Pharm 1999;185:23-35.
Kurup VM, Thomas J. Edible vaccines: promises and challenges. MolBiotechnol 2020;62:79-90.
Gupta RK, Varanelli CL, Griffin P, Wallach DFH, Siber GR. Adjuvant properties of non-phospholipid liposomes (Novasomes®) in experimental animals for human vaccine antigens. Vaccine 1996;14:219-25.
Chambers MA, DC Wright, J Brisker, A Williams, G Hatch, D GavierWidén, et al. A single dose of killed mycobacterium bovis BCG in a novel class of adjuvant (Novasome™) protects guinea pigs from lethal tuberculosis. Vaccine 2004;22:1063-71.
Wright DC. Lipid vesicles having a bilayer containing a surfactant with anti-viral and spermicidal topical delivery of peptide drugs into activity. U. S patent 5561062; 1997.
Pushko P, Tumpey TM, Hoeven NV, Belser JA, Robinson R, Nathan M, et al. Evaluation of influenza virus-like particles and novasome adjuvant as candidate vaccine for avian influenza. Vaccine 2007;25:4283-90.
Holick MF, Chimeh FN, Ray S. Topical PTH (1–34) is a novel, safe and effective treatment for psoriasis: a randomized self-controlled trial and an open trial. Br J Dermatol 2003;149:370-6.
Varanelli C, Kumar S, Wallach DFH. Method of inhibiting viral reproduction using non-phospholipid, pauci lamellar liposomes. U. S. Patent 5,561,062; 1996.
Weiner N, Wallach DFH, Egbaria K, Chandrasekharan R. Stimulation of hair follicles. U. S. Patent 5,834,014; 1998.
Alavi M, Karimi N, Safaei M. Application of various types of liposomes in drug delivery systems. Adv Pharm Bull 2017;7:3-9.
https://www.sec.gov/Archives/edgar/data/352998/000095015607000235/ex1051.htm.[Last accessed on 20 Jul 2020]
Fevola. Methods of improving the activity of retinoids. US patent 2018/0280275 Al; 2018.
Savary G, Gilbert L, Grisel M, Picard C. Instrumental and sensory methodologies to characterize the residual film of topical products applied to skin. Skin Res Technol 2019;25:415-23.
SonnevilleAubrun O, Simonnet JT, L'Alloret F. Nanoemulsions: a new vehicle for skincare products. Adv Colloid Interface Sci 2004;108-9:145-9.
Shah JM, Shah NH, Hadiya PD. Recent advances in novasome formulation technology. Int J Pharm Sci Nanotech 2014;7:2407-11.
Dawn A, Yosipovitch G. Treating itch in psoriasis. DermatolNurs 2006;18:227-33.
Panonnummal R, Sabitha M. Anti-psoriatic and toxicity evaluation of methotrexate loaded chitin nanogel in imiquimod induced mice model. Int J BiolMacromol 2018;110:245-58.